Table 4.
MRI features | Prevalence | Sensitivity | Specificity | Accuracy | PPV | NPV | K | |
---|---|---|---|---|---|---|---|---|
Size > 7 cm | MCAs | 11/43 | 82 | 74 | 77 | 62 | 89 | 0.522 |
MCACs | 18/22 | |||||||
Septa > 3 mm | MCAs | 6/43 | 91 | 86 | 88 | 77 | 95 | 0.737 |
MCACs | 20/22 | |||||||
Wall > 3 mm | MCAs | 8/43 | 86 | 81 | 83 | 70 | 92 | 0.642 |
MCACs | 19/22 | |||||||
Number of cysts > 4 | MCAs | 8/43 | 77 | 81 | 80 | 68 | 87 | 0.568 |
MCACs | 17/22 |
k, κ-Cohen; MCAs, mucinous cystoadenomas; MCACs, mucinous borderline tumours and cystoadenocarcinomas; NPV, negative-predictive value; PPV, positive-predictive value.
The table shows the prevalence in each group (MCAs and MCACs) of quantitative variables at their best cut-off values: size >7 cm, septa thickness >3 mm, wall thickness >3 mm and number of cysts >4, with respective sensitivity, specificity, accuracy, PPV and NPV and agreement on malignancy (k) calculated by the κ-Cohen test.